Eden Research PLC (EDEN)

Industry Agricultural Inputs
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

4.00p

Buy

4.30p

arrow-up0.17p (+4.15%)

Eden Research PLC is a UK based company engaged in the development and marketing of intellectual property, particularly in terpenes and other health related projects. It operates through Biocides and Human health, Animal health and Agrochemical segments.
Prices updated at 19 May 2025, 15:22 BST
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-up0.14%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20162017201820192020202120222023
391,9582m3m2m1m1m2m3m
363,3981m2m883,861632,479561,237830,1602m
-2m-1m-497,036-1m-2m-3m-3m-2m
--71.99-17.92-74.37-163.86-261.14-140.49-58.48
-2m-639,093-334,951-1m-2m-3m-2m-6m
-1m-601,090-102,648-952,166-2m-3m-2m-6m
Sales, General and administrative1m2m2m2m2m3m3m3m
Interest expenses--5518,39724,00032,07422,04617,009
Provision for income taxes-81,895-123,836-198,119-347,036-285,108-618,137-323,716-428,326
Operating expenses2m2m2m2m3m4m3m4m
Income before taxes-2m-762,929-533,070-1m-3m-3m-3m-7m
Net income available to common shareholders-2m-639,093-334,951-1m-2m-3m-2m-6m
-0.010284-0.003295-0.001598-0.005392-0.0066-0.0073-0.0059-0.0154
Net interest income7941,2871,133-7,590-18,275-31,976-21,85416,807
Advertising and promotion--------
Net investment income, net-14,99922,911-23,030-73,16635,706-97,24752,736-68,802
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)-0.010284-0.003295-0.001598-0.005392-0.0066-0.0073-0.0059-0.0154
Free cash flow per share-0.0038-0.0039-0.0052-0.0061-0.0103-0.0068-0.01-0.0034
Book value/share0.04250.0450.03680.0370.04230.03650.03150.0093
Debt equity ratio---0.0063650.0221940.0233180.0201310.006429

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20162017201820192020202120222023
Current assets2m5m3m2m9m6m4m11m
Current liabilities965,2862m875,4041m2m2m2m3m
Total capital7m9m8m7m15m13m11m14m
Total debt---69,499415,248398,352355,323229,769
Total equity7m9m8m7m15m13m11m14m
Total non current liabilities--------
Loans--------
Total assets8m11m9m9m17m15m13m17m
Total liabilities--------
Cash and cash equivalents2m4m2m501,9847m4m2m7m
Common stock185m207m208m208m380m380m381m533m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20162017201820192020202120222023
Cash at beginning of period148,3602m4m2m501,9847m4m2m
Cash dividends paid--------
-1m-242,038-1m-2m-3m-3m-2m-3m
Investments (gains) losses-236,707-446,642-510,934-913,043-2m-2m-1m-2m
2m4m2m501,9847m4m2m7m
Net income--------
-916,952230,041-701,678-1m-1m-2m-683,287-2m
-237,985-472,079-512,618-913,850-2m-2m-1m-2m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.